Your browser doesn't support javascript.
loading
Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant.
Ren, Wenlin; Zhang, Yu; Rao, Juhong; Wang, Ziyi; Lan, Jun; Liu, Kunpeng; Zhang, Xuekai; Hu, Xue; Yang, Chen; Zhong, Guocai; Zhang, Rong; Wang, Xinquan; Shan, Chao; Ding, Qiang.
Afiliação
  • Ren W; Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China.
  • Zhang Y; Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China.
  • Rao J; State Key Laboratory of Virology, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Wang Z; University of Chinese Academy of Sciences, Beijing, China.
  • Lan J; School of Life Sciences, Tsinghua University, Beijing, China.
  • Liu K; School of Life Sciences, Tsinghua University, Beijing, China.
  • Zhang X; State Key Laboratory of Virology, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Hu X; University of Chinese Academy of Sciences, Beijing, China.
  • Yang C; State Key Laboratory of Virology, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Zhong G; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang R; State Key Laboratory of Virology, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Wang X; Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China.
  • Shan C; Shenzhen Bay Laboratory, Shenzhen, China.
  • Ding Q; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.
mBio ; 14(2): e0041623, 2023 04 25.
Article em En | MEDLINE | ID: mdl-37010428
ABSTRACT
Recently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.529 (Omicron) has rapidly become the dominant strain, with an unprecedented number of mutations within its spike gene. However, it remains unknown whether these variants have alterations in their entry efficiency, host tropism, and sensitivity to neutralizing antibodies and entry inhibitors. In this study, we found that Omicron spike has evolved to escape neutralization by three-dose inactivated-vaccine-elicited immunity but remains sensitive to an angiotensin-converting enzyme 2 (ACE2) decoy receptor. Moreover, Omicron spike could use human ACE2 with a slightly increased efficiency while gaining a significantly increased binding affinity for a mouse ACE2 ortholog, which exhibits limited binding with wild-type (WT) spike. Furthermore, Omicron could infect wild-type C57BL/6 mice and cause histopathological changes in the lungs. Collectively, our results reveal that evasion of neutralization by vaccine-elicited antibodies and enhanced human and mouse ACE2 receptor engagement may contribute to the expanded host range and rapid spread of the Omicron variant. IMPORTANCE The recently emerged SARS-CoV-2 Omicron variant with numerous mutations in the spike protein has rapidly become the dominant strain, thereby raising concerns about the effectiveness of vaccines. Here, we found that the Omicron variant exhibits a reduced sensitivity to serum neutralizing activity induced by a three-dose inactivated vaccine but remains sensitive to entry inhibitors or an ACE2-Ig decoy receptor. Compared with the ancestor strain isolated in early 2020, the spike protein of Omicron utilizes the human ACE2 receptor with enhanced efficiency while gaining the ability to utilize mouse ACE2 for cell entry. Moreover, Omicron could infect wild-type mice and cause pathological changes in the lungs. These results reveal that antibody evasion, enhanced human ACE2 utilization, and an expanded host range may contribute to its rapid spread.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Evasão da Resposta Imune / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Evasão da Resposta Imune / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article